Comparison of Sugammadex and Neostigmine/Glycopyrrolate in Reversing Neuromuscular Blockade in Adults Using Neuromuscular Monitor
International Journal of Current Pharmaceutical Review and Research · 30.06.2026 · 18 (06)
DOI: 10.25258/ijcpr.18.6.7 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.06.2026. Verfasst von Kallol Ganguly und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Neostigmine, the conventional agent for neuromuscular blockade reversal, acts indirectly by inhibiting acetylcholinesterase and is associated with unpredictable recovery times and muscarinic side effects. Sugammadex, a modified γ-cyclodextrin, reverses steroidal neuromuscular blocking agents by direct encapsulation, offering the potential for rapid and predictable reversal. While prior studies demonstrated its efficacy in deep blockade, evidence comparing both agents in moderate blockade under inhalational anaesthesia was limited.
Methods
One hundred twenty patients, of either sex, ASA physical status I or II, undergoing elective Laparoscopic cholecystectomy under general anaesthesia, were randomly allocated into two groups containing sixty patients each. Group A received Sugammadex for Reversal of muscle relaxant and Group B received Neostigmine/Glycopyrrolate for Reversal of Muscle Relaxant.
Results
Sugammadex achieved TOF ≥ 0.9 significantly faster than Neostigmine (89 second versus 399 second, P < 0.0001). 98% of patients receiving Sugammadex recovered within 2 minutes showing greater predictability, while with neostigmine some patients required more than 7 minutes to recover.
Conclusion
Sugammadex provides markedly faster, more predictable, and reliable reversal of moderate rocuronium-induced neuromuscular blockade compared with neostigmine during sevoflurane anaesthesia, with a comparable safety profile.
Zitieren
APA
Ganguly, K., Chakraverty, P., Saha, S., & Gupta, D. (2026). Comparison of Sugammadex and Neostigmine/Glycopyrrolate in Reversing Neuromuscular Blockade in Adults Using Neuromuscular Monitor. International Journal of Current Pharmaceutical Review and Research, 18(06). https://doi.org/10.25258/ijcpr.18.6.7
Vancouver
Ganguly K, Chakraverty P, Saha S, Gupta D. Comparison of Sugammadex and Neostigmine/Glycopyrrolate in Reversing Neuromuscular Blockade in Adults Using Neuromuscular Monitor. International Journal of Current Pharmaceutical Review and Research. 2026;18(06). doi:10.25258/ijcpr.18.6.7
BibTeX
@article{Ganguly2026,
author = {Ganguly, Kallol and Chakraverty, Prithviraj and Saha, Subhashis and Gupta, Debjani},
title = {Comparison of Sugammadex and Neostigmine/Glycopyrrolate in Reversing Neuromuscular Blockade in Adults Using Neuromuscular Monitor},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {06},
doi = {10.25258/ijcpr.18.6.7}
}
EUVIMED